Background Endoscopic retrograde cholangiopancreatography (ERCP) and related procedures can cause abdominal pain and discomfort. Two clinical trials have indicated, using the visual analogue scale (VAS) score, that CO 2 insufflation during ERCP ameliorates the suffering of patients without complications, compared with air insufflation. However, differences in patient suffering between CO 2 and air insufflation after ERCP under deep conscious sedation have not been reported. We focused on the gas volume score (GVS) as an objective indicator of gas volume, and designed a multicenter, prospective, double-blind, randomized, controlled study with CO 2 and air insufflation during ERCP. Methods Between March 2010 and August 2010, 80 patients who required ERCP were enrolled and evenly randomized to receive CO 2 insufflation (CO 2 group) or air insufflation (air group). ERCP and related procedures were performed under deep conscious sedation with fentanyl citrate or pethidine and midazolam or diazepam. The GVS was evaluated as the primary endpoint in addition to the VAS score as the secondary endpoint.
have indicated that CO 2 insufflation during colonoscopy ameliorates the suffering of patients with no associated complications compared with air insufflation. Two reports on the effects of CO 2 insufflation during ERCP revealed that the frequency of abdominal pain and distension after ERCP in the CO 2 group was lower than that in the air group and that the frequency of complications in both groups was comparable [3, 4] . However, differences in abdominal pain and discomfort between patients undergoing ERCP with CO 2 insufflation and room air under deep conscious sedation with opioid drugs and benzodiazepines have not been evaluated. Furthermore, visual analogue scale (VAS) scores obtained from patients after ERCP, which was the primary end point in the two previous reports [3, 4] , lack objectivity because patients' susceptibility to pain and discomfort from the same stimulation vary, and scoring by patients themselves is not absolute for quantification.
We speculated that the increase in the gastrointestinal gas volume in patients after ERCP and related procedures would result in an increase in the severity of abdominal pain, distension, and nausea. In addition, we determined that the quantification of gastrointestinal gas volume would lead to a more accurate evaluation of the symptoms mentioned above. Therefore, we focused on the gas volume score (GVS) reported by Koide et al. [5] as an objective indicator of gas volume, and we designed the present study as a multicenter, prospective, double-blind, randomized, controlled study. The effects of CO 2 and air insufflation during ERCP were analyzed using GVS as the primary end point in addition to the VAS score as the secondary end point.
Materials and methods

Study design
This study was conducted as a prospective, multicenter, double-blind, randomized, controlled trial. Patients were assigned to two groups: CO 2 group and an air group. The study protocol was approved by the institutional review boards of each participating institution (Hokkaido University Hospital, clinical research approval number 009-0216; Sapporo Medical University Hospital, clinical research approval number 21-118).
Patients
Between March 2010 and August 2010, all consecutive patients with pancreatobiliary disease or disorders that required ERCP for workup or treatment who presented to our department at Hokkaido University Hospital or Sapporo Medical University Hospital were screened for recruitment. The exclusion criteria for patients were as follows: (1) refusal to provide informed consent; (2) poor general status (performance status 4: completely disabled, cannot perform any self-care, and totally confined to the bed); (3) younger than age 20 years; (4) inaccessibility of the papilla of Vater for endoscopic examination; (5) acute pancreatitis; (6) chronic pancreatitis with acute exacerbation; (7) severe heart dysfunction; (8) chronic obstructive pulmonary disease; (9) pregnancy; (10) stricture of the digestive tract; (11) abdominal pain before ERCP; (12) use of sedative drugs (within 12 h) before ERCP; and (13) judged inappropriate by a doctor. A total of 80 patients were included in the study, and written informed consent was obtained from all patients. The patients enrolled in the study were admitted to the two university hospitals mentioned above, and they underwent ERCP and related procedures.
Randomization and blinding of the study Enrolled patients were evenly randomized between the CO 2 insufflation group (CO 2 group, n = 40) and the air insufflation group (air group, n = 40) by using a computergenerated sequence just before ERCP. A clinical engineer set the gas insufflation system to CO 2 or air according to the result of randomization. CO 2 was administered by using a commercially available CO 2 regulator designed for use in endoscopic procedures (Olympus Medical Systems, Tokyo, Japan). The patients, endoscopists, assistants, and X-ray image and VAS score analysts were all blinded with regard to the type of gas used. Unblinding was prevented by concealing the lumps indicating actuation of the CO 2 device and the air inlet button on the endoscopy rack using thick paper screens.
Endoscopic retrograde cholangiopancreatography ERCP and related procedures were performed as previously reported under deep conscious sedation with fentanyl citrate or pethidine and midazolam or diazepam [6] . The operator and assistants determined the level of sedation in each patient and increased the doses of the sedative drugs until deep sedation was achieved, as indicated by the somnolent condition of the patient. Administration of antispastic drugs, scopolamine butylbromide or glucagon, and oxygen supply by nasal tube (2-3 l/min) also were appropriately performed. Bile duct or main pancreatic duct (MPD) cannulation were performed using wire-guided cannulation (WGC) with a triple-lumen papillotome (CleverCut3V, Olympus) [1] [2] [3] [4] 8] .
Accidents were classified using the Cotton classification [9] . On the basis of a consensus meeting held in 1991, the diagnostic criteria for post-ERCP pancreatitis are abdominal pain lasting [24 h after ERCP and hyperamylasemia ([3 times the upper limit of the normal range). The Cotton classification was used for the assessment of severity, but on the basis of the medical circumstances in Japan, the time leading up to food consumption was used as an indicator of the severity rather than the duration of hospitalization [7] .
Bowel gas volume was quantified using abdominal X-ray photographs as follows. Plain abdominal radiographs in the supine position taken just before and 5 min after ERCP were digitized and transmitted to a computer. After the region of bowel gas was identified, its outline was traced on the monitor and distinguished from other areas by image adjustment (contrast enhancement). The total quantity of bowel gas was determined by counting the pixel value of the resulting images. ImageJ version 1.43, which was developed by Dr. Wayne Rasband and colleagues at the National Institutes of Health (http://rsb.info.nih.gov/ij/), was used to measure the pixel value. The measurements of bowel gas were standardized using physical parameters by calculating the ratio of the quantity of bowel gas to the pixel value in a region surrounded by a horizontal line tangential to the upper margin of the pubic bone, a horizontal line tangential to the uppermost diaphragm, and the most lateral line tangential to the right and left coastal arches, which was defined as the GVS as previously reported [5] (Fig. 1) . The GVS was set as the primary end point. Furthermore, the rate of increase in GVS ([GVS after -GVS before]/[GVS before ERCP and related procedures] 9 100) was calculated to remove the potential bias generated by the gas volume before ERCP and related procedures.
A 10-point visual analogue scale (VAS) was used as the secondary end point in this study to quantify abdominal pain and discomfort (distension and nausea) experienced during ERCP and 3 and 24 h after ERCP and related procedures, as described in recent studies [3, 4, 8] . A sheet describing the VAS was given to each participant after the Fig. 1 Calculation of the gas volume score (GVS) using plain abdominal X-ray images of a representative patient (A). The bowel gas (B) area was determined and is indicated by the black region. The GVS is expressed as the black area in (B) divided by the total of the black and white areas (the values were 390,177/3,145,728 pixels). The GVS in the example shown was 0.124 procedure to be filled out the next day and collected. In addition, ERCP and related procedures performed within 30 and [30 min were defined as short and long time procedures, respectively. Sample size Sample size was determined by power calculation. On the basis of previous data (not shown), the air group was speculated to have an approximately 1.5-fold to 2-fold higher mean abdominal gas volume in the X-ray images just after ERCP compared with the CO 2 group. To detect this difference with a power of 0.8 and an alpha of 0.05, complete data were required for at least 36 patients per group. Therefore, assuming the dropout of 10% of the enrolled patients, the present recruitment goal was a total of 80 patients.
Statistical analysis
Categorical data were examined using the v 2 test. The Mann-Whitney U test or t test were used for comparison of quantitative data. Spearman correlation analysis was performed for the test of correlations. These tests were performed with Microsoft Excel software (Redmond, WA), and the results were regarded as significant if P \ 0.05. This study is registered in the University Hospital Medical Information Network (UMIN ID: UMIN000003062).
Results
A total of 80 patients who required ERCP were enrolled in the study after the application of exclusion criteria as described above. ERCP and its related procedures were performed by CO 2 or air insufflation on the basis of the randomization of patients (Fig. 2) . Table 1 shows the characteristics of the 80 patients. There were no significant differences in patient number, age, sex, and disease between the CO 2 and the air groups.
The GVS was first estimated as the primary and objective end point. Table 2 shows the GVS values of both the CO 2 and air groups. The GVS before ERCP and related procedures did not show significant differences between the two groups (0.11 ± 0.04 vs. 0.1 ± 0.05). However, the GVS after ERCP and related procedures in the CO 2 group was significantly lower than that in the air group (0.14 ± 0.06 vs. 0.31 ± 0.11, P \ 0.01). The rate of increase in GVS (%) in the CO 2 group also was significantly lower than that in the air group (3.8 ± 5.9 vs. 21 ± 11.1%, P \ 0.01). The total time of the procedure, which appeared to affect GVS values, was similar between both groups (2,700 ± 1,485 vs. 2,582 ± 1,345 s). The relationship between the length of the procedure and GVS also was analyzed (Table 3 ). In patients with short procedure times (within 30 min), GVS significantly differed between the CO 2 and air groups (P \ 0.01), whereas in patients with long procedure times ([30 min), the result was the same. The GVS values among patients within the CO 2 group and the air group were similar between the short and long procedures.
The VAS scores for abdominal pain, distension, and nausea were next evaluated after ERCP and related procedures as the secondary end point. As shown in Table 4 , VAS scores 3 and 24 h after ERCP and related procedures were not significantly different between the CO 2 and air groups with regard to abdominal pain (3 h, 1.4 ± 2 vs. 0.9 ± 2; 24 h, 1.1 ± 1.9 vs. 0.5 ± 1.3), abdominal distension (3 h, 0.6 ± 1.2 vs. 0.6 ± 1.1; 24 h, 0.6 ± 1.6 vs. 0.4 ± 1.1), and nausea (3 h, 0.2 ± 0.8 vs. 0.2 ± 0.9; 24 h, 0.2 ± 0.9 vs. 0.1 ± 0.3). Unexpectedly, the VAS scores for abdominal pain, distension, and nausea were not correlated with the GVS values (Spearman's correlation coefficient: 3 h, 0.01, 0.03, and 0.16; 24 h, 0.05, 0.01, and 0.17, respectively). Furthermore, the effect of CO 2 and air insufflation on the doses of sedative and antispastic drugs administered during the procedures was assessed ( Table 4) . The sedative drugs, fentanyl citrate (100-200 lg) or pethidine (17.5-35 mg) and midazolam (2-15 mg) or diazepam (1-3 mg), were used. There were no significant differences among the groups in the drug doses except for pethidine (P \ 0. Arterial oxygen saturation levels were measured in all patients by using a pulse oximeter (SpO 2 ) to assess the effect of CO 2 or air insufflation before, during, and 3 and 24 h after ERCP and related procedures. In both the CO 2 and air groups, SpO 2 did not change before and after the procedures (CO 2 group: before, 97.8 ± 1.3%; 3 h after, 97.1 ± 1.4%; 24 h after, 97.2 ± 1.4%; air group: before, 97.7 ± 1.3%; 3 h after, 96.6 ± 1.3%; 24 h after, 97 ± 1.2%; Fig. 3 ). The routine administration of oxygen during the procedure by nasal tube (2-3 l/min) did not cause changes in SpO 2 in either the CO 2 or air groups.
Complications associated with the procedure are shown in Table 5 . The total number of complications was the same in both the CO 2 and air groups (4 vs. 4). Post-ERCP pancreatitis (PEP) was the most frequent complication in both groups (4 cases vs. 3 cases). PEP was mild or moderate in all cases (mild in 2 and moderate in 5 cases), and it was cured by conservative therapies. Other complications included retroperitoneal perforation in one case in the air group who was also cured by noninvasive therapies.
Discussion
The utility of CO 2 insufflation during ERCP has been described in previous reports, which demonstrated a reduction in abdominal pain and discomfort in patients NS not significant undergoing ERCP with CO 2 insufflation compared with those treated by air insufflation [3, 4] . This result also was reported for colonoscopy patients [1, 2] . However, a different study reported that there were no advantages of CO 2 insufflation during ERCP in terms of a reduction in symptoms [8] . The studies that reported the advantages of CO 2 insufflation during endoscopy used VAS scores for abdominal pain and discomfort as indicators of patient suffering after endoscopy [1] [2] [3] [4] . However, differences in VAS scores (for abdominal pain and discomfort) between patients treated with CO 2 and air insufflation after ERCP under deep conscious sedation in Japan have not been reported. In addition, the VAS score itself is not an absolute indicator. On the other hand, Koide et al. [5] reported that the GVS is reproducible and very objective.
First, we validated the availability of the GVS as a new surrogate and objective marker of patients' stress after ERCP. GVS values revealed that remnant gastrointestinal gas volume after ERCP was significantly lower in the CO 2 group than that in the air group regardless of the length of the procedure (Tables 2, 3) . It was quantitatively demonstrated that less gastrointestinal gas volume in the CO 2 insufflation group in the two previous reports on ERCP led to a reduction in patients' suffering [3, 4] . However, because the results of the present study show that there is no correlation between the GVS and VAS scores, GVS is not considered a useful marker of patient suffering after ERCP under deep conscious sedation. This difference between the present and previous results could be attributed to differences in the degree of conscious sedation (deep vs. moderate) and the speed of recovery of consciousness (late vs. early) [3, 4] . Under conditions of no, mild, or moderate conscious sedation, we hypothesize that the GVS and VAS scores would be strongly correlated for endoscopy, including ERCP, and the superiority of CO 2 insufflation would be more objectively and quantitatively verified by the GVS under these conditions [1] [2] [3] [4] .
The VAS score as a method for the evaluation of patient suffering after ERCP with CO 2 or air insufflation under deep conscious sedation also was assessed. Patients and blood samples are commonly evaluated 3 and 24 h after ERCP to identify the presence or absence of complications. It is therefore relatively simple to record VAS scores at these two times. In addition, on the basis of our experience, patients with abdominal pain, distension, or nausea after ERCP usually complain of symptoms within 3 h after ERCP or the next day. On the basis of these two reasons, VAS scores were checked at 3 and 24 h after ERCP in the present study. This was, however, considered a limitation and bias of our study, the results of which showed that VAS scores 3 and 24 h after ERCP were not statistically different between the two insufflation groups (Table 4) . Although the VAS score of abdominal pain in the CO 2 group was slightly higher than in the air group, this was likely caused by the higher frequency of moderate pancreatitis after ERCP (4 vs. 1 case) in the CO 2 group than in the air group (data not shown).
Unexpectedly, the VAS scores in both insufflation groups were consistently low. The half-lives of the sedative drugs fentanyl citrate, pethidine, midazolam, and diazepam are 3.6, 3.5, 2.5, and 34.9 h, respectively. The assessment of VAS scores 3 h after ERCP under deep conscious sedation is therefore difficult. In addition, although the assessment of VAS scores is possible at 24 h after ERCP, at this time the bowel has usually started to move and both CO 2 and air in the bowel have already been excreted or absorbed. The results of the present study show that deep conscious sedation during ERCP has a similar effect on the alleviation of patient suffering after ERCP as well as CO 2 Fig. 3 Time course of arterial oxygen saturation levels by pulse oximeter (SpO 2 ). There was no significant difference between the CO 2 and the air groups at any time point by t test e Hypotension was defined as a decrease in systolic blood pressure to \80 mmHg insufflation to that under mild conscious sedation, although the comparative study between mild or moderate versus deep conscious sedation is mandatory. With regard to the level of sedation during ERCP, moderate to deep sedation with opioid (pethidine) plus benzodiazepines or propofol alone is generally recommended in the United States [10] and Europe [11] . Recent reports have demonstrated that under air insufflation, deep sedation with propofol alone or propofol plus sedatives during ERCP show better results for patients and endoscopists than moderate sedation [12] [13] [14] . This indicates that strong sedation during ERCP is beneficial not only to alleviate pain in patients but also to reduce endoscopists' stress regardless of the type of gas used for insufflation. However, because a distended bowel can frequently limit or prevent the flexibility and controllability of the endoscope, CO 2 insufflation during ERCP is preferable to air insufflation to reduce stomach and duodenal distension. Furthermore, another advantage of CO 2 insufflation during ERCP is that a reduction in GVS, in other words, less bowel gas during fluoroscopy, greatly improves the resolution of cholangiograms or pancreatograms.
The frequency of complications associated with ERCP and related procedures in the present study (10%) was similar to that previously reported (5-10%) [15] , and it was comparable among the groups in this study. However, CO 2 insufflation would be required in cases with the risk of perforation of the duodenum following difficult endoscopic sphincterotomy (ES) or papillectomy, or in patients with choledocholithiasis after ES who undergo endoscopic treatment. This assumption is based on good absorption of CO 2 and previous reports of air embolism during ERCP [16, 17] .
In conclusion, CO 2 insufflation during ERCP reduces GVS (bowel gas volume), but not the VAS score of suffering, as compared with air insufflation. In addition, deep and sufficient sedation during ERCP and related procedures is important for palliation of pain and discomfort of patients.
